Tools for cardiovascular risk assessment in clinical practice

被引:0
|
作者
Cainzos-Achirica M. [1 ,2 ]
Eissler K. [2 ]
Blaha M.J. [1 ,2 ]
Blumenthal R.S. [2 ]
Martin S.S. [1 ,2 ]
机构
[1] Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD
[2] Ciccarone Center for the Prevention of Heart Disease, Division of Cardiology, Johns Hopkins Medical Institutions, Carnegie 568A, Baltimore, 21287, MD
基金
美国国家卫生研究院;
关键词
Absolute cardiovascular risk; Ankle-brachial index; Atherosclerosis; Cardiovascular disease; Carotid intima-media thickness; Carotid plaque; Coronary artery calcium; Family history; High-sensitivity C-reactive protein; Prevention; Risk assessment; Risk management; Risk scores; Serum biomarkers; Traditional risk factors;
D O I
10.1007/s12170-015-0455-4
中图分类号
学科分类号
摘要
Precise risk stratification of atherosclerotic cardiovascular disease guides best management and therefore is a public health priority. In addition to risk estimation using traditional risk factors, tools such as coronary artery calcium, high-sensitivity C-reactive protein, ankle-brachial index and carotid imaging, and clinical features such as family history of premature coronary heart disease may offer opportunities for a more personalized risk assessment. In this review, we discuss the strengths and limitations of each of these tools, focusing on the evidence provided by the latest studies relevant to the field. Among them, coronary artery calcium currently stands out as the most powerful tool for cardiovascular risk assessment, as recognized by the 2013 ACC/AHA Risk Assessment Guideline. Recent studies have expanded our knowledge regarding its value for improving the detection of both low and high absolute risk within clinically relevant subgroups, as well as for cost-effectively guiding preventive therapy allocation. © 2015, Springer Science+Business Media New York.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools
    Kirby, M.
    Machen, I.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (12) : 1683 - 1692
  • [2] Cardiovascular risk: its assessment in clinical practice
    Wilson, SL
    Poulter, NR
    [J]. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2001, 58 (04) : 248 - 251
  • [3] The Challenges and Benefits of Cardiovascular Risk Assessment in Clinical Practice
    Grover, Steven A.
    Lowensteyn, Ilka
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (04) : 481 - 487
  • [4] Assessment of homocysteine as a cardiovascular risk factor in clinical practice
    Clarke, R
    Stansbie, D
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2001, 38 : 624 - 632
  • [5] Cardiovascular risk assessment tools in Asia
    Zhang, Yuqing
    Miao, Huanhuan
    Chia, Yook-Chin
    Buranakitjaroen, Peera
    Siddique, Saulat
    Shin, Jinho
    Turana, Yuda
    Park, Sungha
    Tsoi, Kelvin
    Chen, Chen-Huan
    Cheng, Hao-Min
    Li, Yan
    Huynh Van Minh
    Nagai, Michiaki
    Nailes, Jennifer
    Sison, Jorge
    Soenarta, Arieska Ann
    Sogunuru, Guru Prasad
    Sukonthasarn, Apichard
    Tay, Jam Chin
    Teo, Boon Wee
    Verma, Narsingh
    Wang, Tzung-Dau
    Hoshide, Satoshi
    Kario, Kazuomi
    Wang, Jiguang
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (04): : 369 - 377
  • [6] Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice
    Law, Tamryn K.
    Yan, Andrew T.
    Gupta, Aanika
    Kajil, Mahesh
    Tsigoulis, Michelle
    Singh, Narendra
    Verma, Subodh
    Gupta, Milan
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2015, 1 (01) : 31 - 36
  • [7] RISK FACTOR ASSESSMENT FOR THE PREVENTION OF PREMATURE CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
    Halcox, Julian P.
    Gollop, Nicholas D.
    Lacey, Arron S.
    King, William H.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1432 - E1432
  • [8] Risk factor assessment for the prevention of premature cardiovascular disease in clinical practice
    Gollop, N. D.
    Lacey, A. S.
    King, W. H.
    Halcox, J. H.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 122 - 123
  • [9] Review of tools of cardiovascular disease risk stratification: interpretation, customisation and application in clinical practice
    Chia, Y. C.
    [J]. SINGAPORE MEDICAL JOURNAL, 2011, 52 (02) : 116 - 123
  • [10] Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?
    Kalhan, Atul
    Rees, Alan
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (04) : 321 - 323